Masthead small

Choosing Wisely: Things Physicians and Patients Should Question

In February 2016, the Society for Maternal-Fetal Medicine (SMFM) released its list of “Five More Things Physicians and Patients Should Question” in high-risk obstetrics as part of the Choosing Wisely® campaign, led by the American Board of Internal Medicine (ABIM) Foundation.  This list builds on the original "Five Things Physicians and Patients Should Question" released in February 2014. 

SMFM’s list includes ten evidence-based recommendations that can support maternal-fetal medicine subspecialists and their patients in making wise choices about their care.  The items included in the list were developed by the SMFM Publications Committee based on a review of the literature and evidence from SMFM’s published documents. The combined list of items include the following:

  1. Don’t do an inherited thrombophilia evaluation for women with histories of pregnancy loss, intrauterine growth restriction (IUGR), preeclampsia and abruption.
  2. Don’t place a cerclage in women with short cervix who are pregnant with twins.
  3. Don’t offer noninvasive prenatal testing (NIPT) to low-risk patients or make irreversible decisions based on the results of this screening test.
  4. Don’t screen for intrauterine growth restriction (IUGR) with Doppler blood  flow  studies.
  5. Don’t use progestogens for preterm birth prevention in uncomplicated multifetal gestations.
  6. Don't perform routine cervical length screening for preterm birth risk assessment in asymptomatic women before 16 weeks of gestation or beyond 24 weeks of gestation.
  7. Don't perform antenatal testing on women with the diagnosis of gestational diabetes who are well controlled by diet alone and without other indications for testing.
  8. Don't place women, even those at high-risk, on activity restriction to prevent preterm birth.
  9. Don't order serum aneuploidy screening after cfDNA aneuploidy screening has already been performed.
  10. Don't perform maternal serologic studies for cytomegalovirus and toxoplasma as part of routine prenatal laboratory studies.


back